title: Update on Clinical Utility of Continuous Glucose Monitoring in Type 1 Diabetes.
abstract: Since the early 2000s, continuous glucose monitoring (CGM) technology has advanced to become a standard of care in the treatment of type 1 diabetes. Unfortunately, CGM use is not commonly integrated into practice. This article will review the history, technology, and need for systematic training in CGM. Additionally, it will review recent clinical trial data demonstrating the benefits that CGM offers to all people with type 1 diabetes and the clinicians who care for them.
authors.affiliation: Advanced Metabolic Care and Research, 625 W. Citracado Pkwy, Ste 108, Escondido, CA, 92025, USA.
authors.forename: Nalani
authors.initials: N
authors.lastname: Haviland
authors.affiliation: Advanced Metabolic Care and Research, 625 W. Citracado Pkwy, Ste 108, Escondido, CA, 92025, USA.
authors.forename: John
authors.initials: J
authors.lastname: Walsh
authors.affiliation: Diabetes Services, Inc., 1030 West Upas St., San Diego, CA, 92103, USA.
authors.forename: Ruth
authors.initials: R
authors.lastname: Roberts
authors.affiliation: AMCR Institute, 625 West Citracado Parkway Suite 112, Escondido, CA, 92025, USA. tbailey@amcrinstitute.com.
authors.forename: Timothy S
authors.initials: TS
authors.lastname: Bailey
mesh_terms: D001786:Blood Glucose / Q000032:analysis*; D015190:Blood Glucose Self-Monitoring; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy*; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans
chemical_list: D001786:Blood Glucose; D006442:Glycated Hemoglobin; C517652:hemoglobin A1c protein, human
keywords: Artificial pancreas; CGM; Continuous glucose monitoring; Insulin therapy; Type 1 diabetes